AF
VRTX icon

Aviso Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Aviso Financial’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-476
Closed -$213K – 350
2026
Q1 		$213K Sell
476
-2,576
-84% -$1.2M 0.01% 216
2025
Q4 		$1.38M Sell
3,052
-113
-4% -$48.7K 0.05% 129
2025
Q3 		$1.24M Buy
3,165
+1,321
+72% +$552K 0.05% 146
2025
Q2 		$821K Sell
1,844
-6
-0.3% -$2.77K 0.04% 170
2025
Q1 		$897K Buy
1,850
+647
+54% +$302K 0.04% 154
2024
Q4 		$484K Buy
1,203
+16
+1% +$7.42K 0.02% 204
2024
Q3 		$552K Buy
1,187
+222
+23% +$107K 0.03% 195
2024
Q2 		$452K Buy
+965
New +$419K 0.03% 191

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Aviso Financial's VRTX Position: Q2 2026 in Review

Aviso Financial sold out of Vertex Pharmaceuticals (VRTX) in Q2 2026, closing a stake of 476 shares — an estimated $213K sold.

Aviso Financial first reported a position in VRTX in Q2 2024 and held it in 8 quarters. The position peaked at $1.38M in Q4 2025. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Aviso Financial reported no remaining Vertex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Aviso Financial sold 476 Vertex Pharmaceuticals shares in Q2 2026, an estimated $213K.
  • Aviso Financial first reported a position in Vertex Pharmaceuticals in Q2 2024 and held it in 8 quarters.
  • Aviso Financial's Vertex Pharmaceuticals position peaked at $1.38M in Q4 2025.
  • 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Aviso Financial's 13F filing for Q2 2026, filed 13 Aug 2026.